Avacta inks licence agreement with Point Biopharma to provide access to drug platform

Retrieved on: 2021-01-07 08:03:45

Tags for this article:

Click the tags to see associated articles and topics

Avacta inks licence agreement with Point Biopharma to provide access to drug platform. View article details on hiswai:

Excerpt

StockMarketWire.com - Cancer therapies and diagnostics group Avacta said it had entered into a license agreement with Point Biopharma to provide ...

Article found on: www.stockmarketwire.com